Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.99 HKD | +0.10% | +6.28% | -3.01% |
Mar. 26 | Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 12 | Mega Genomics Stockholders to Vote March 1 on Continuing Transactions | MT |
Sales 2022 | 146M 20.12M 157M | Sales 2023 | 151M 20.88M 163M | Capitalization | 2.23B 307M 2.4B |
---|---|---|---|---|---|
Net income 2022 | -17M -2.35M -18.33M | Net income 2023 | 30M 4.14M 32.34M | EV / Sales 2022 | 16.1 x |
Net cash position 2022 | 398M 54.88M 429M | Net cash position 2023 | 478M 65.94M 515M | EV / Sales 2023 | 11.6 x |
P/E ratio 2022 |
-128
x | P/E ratio 2023 |
66
x | Employees | 229 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.86% |
1 day | +0.10% | ||
1 week | +6.28% | ||
Current month | -5.75% | ||
1 month | -6.46% | ||
3 months | +10.75% | ||
6 months | +27.91% | ||
Current year | -3.01% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Jiang
CEO | Chief Executive Officer | 44 | - |
Xiang Yi
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Xia An
COO | Chief Operating Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Yu
FOU | Founder | 52 | 21-04-21 |
Mei Ling Guo
BRD | Director/Board Member | 54 | 21-08-05 |
Lin Lin
CHM | Chairman | 48 | 21-04-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 9.99 | +0.10% | 47 200 |
24-06-05 | 9.98 | +1.84% | 131,000 |
24-06-04 | 9.8 | -1.90% | 0 |
24-06-03 | 9.99 | -5.75% | 124,000 |
24-05-31 | 10.6 | +8.05% | 169,200 |
Delayed Quote Hong Kong S.E., June 06, 2024 at 04:08 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.01% | 302M | |
-22.94% | 7.77B | |
+76.70% | 4.51B | |
+6.87% | 2.76B | |
-2.63% | 2.67B | |
-49.74% | 2.09B | |
-18.51% | 1.72B | |
-19.46% | 1.49B | |
+20.88% | 1.22B | |
-45.82% | 1.12B |
- Stock Market
- Equities
- 6667 Stock